CORE
🇺🇦
make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
CRISPR/Cas9技术及其在药物研发中的应用
Authors
李莉
邓贤明
陆娣
Publication date
12 January 2018
Publisher
'American Society of Ichthyologists and Herpetologists (ASIH)'
Doi
Cite
Abstract
CRISPR/Cas9系统是在细菌和古细菌中发现的一种为抵御病毒和质粒的不断攻击而演化来的获得性免疫防御机制,由规律成簇的间隔短回文重复(clustered regularly interspaced short palindromic repeats,CRISPR)和Cas(CRISPR-associated)蛋白组成。通过改造最简单的II型CRISPR系统,将特殊小向导RNA(small guide RNA,sg RNA)和Cas9核酸内切酶导入细胞内,即可在双链DNA特定位置上进行切割并实现基因敲除或敲入。CRISPR/Cas9系统因其高效基因编辑功能,已被应用于多种生物和多项科研领域。本文综合论述了CRISPR/Cas9技术在药物研发中的应用,如功能基因的筛选和定点编辑、药物靶点筛选和验证、动物模型构建和遗传疾病治疗等,总结了CRISPR/Cas9技术目前所存在的缺陷与改善的方向。国家自然科学基金资助项目(81422045,81603131
Similar works
Full text
Open in the Core reader
Download PDF
Available Versions
Xiamen University Institutional Repository
See this paper in CORE
Go to the repository landing page
Download from data provider
oai:dspace.xmu.edu.cn:2288/173...
Last time updated on 10/06/2020